Business Wire

Pragmatic Welcomes HRH The Princess Royal to Pragmatic Park for the Opening of the UK's First 300mm Semiconductor Wafer Manufacturing Facility

27.3.2024 14:13:00 EET | Business Wire | Press release

Share

Today, Pragmatic Semiconductor was honoured to welcome HRH The Princess Royal to officially open the UK’s first 300mm semiconductor wafer fabrication line (fab) at Pragmatic Park in Durham. The advanced manufacturing facility produces chips based on Pragmatic’s innovative and unique flexible integrated circuit technology. HRH The Princess Royal was hosted by David Moore, CEO, Pragmatic Semiconductor, with a tour of the clean room and facilities, followed by an unveiling of a site plaque to mark the occasion. Attendees included key customers, ecosystem partners, investors and government officials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240327583783/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The UK’s first 300mm semiconductor fabrication line at Pragmatic Park, Durham, UK (Photo: Business Wire)

Pragmatic’s FlexICs are low-cost, more sustainable alternatives to silicon chips, ultra-thin, with a flexible form factor they enable connect, sense and compute capabilities, fuelling the Internet of Things (IoT) across multiple sectors including consumer, industrial, healthcare and beyond. The company’s mission is to provide item level intelligence to trillions of smart objects over the next decade across a wide range of applications with significant opportunities in smart packaging of fast-moving consumer goods that will significantly improve levels of reuse and recycling, transforming waste management, and enabling a circular economy. Other use cases include wearables, sensors and flexible controllers.

Pragmatic Park has capacity to host up to nine fabrication lines, each capable of producing billions of chips per year. Pragmatic’s pioneering sustainable approach extends to its manufacturing, using fewer process steps and a more concentrated footprint, than standard silicon fabs. The company’s innovative, optimised manufacturing process supports extremely rapid production cycles of less than 48 hours, at very low cost. The manufacturing process also uses significantly less energy and less water than typical silicon manufacturing, and fewer harmful gases. Pragmatic’s modular ‘Fab-in-a-Box’ approach, supports co-location of end-to-end FlexIC manufacturing at customers sites, rationalising extended supply chains and providing additional levels of security and resilience. The manufacturing facility enables the company to meet the growing demand for its unique technology from customers worldwide. Over the next five years Pragmatic anticipates creating over 500 highly skilled jobs in the North-East of England and Cambridge.

Dave Moore, CEO, Pragmatic Semiconductor said: "Today’s official opening marks a key milestone in Pragmatic’s growth trajectory and for the UK on the global semiconductor stage. I am incredibly proud of what the team has achieved and the ambition of our mission to enable item level intelligence in over a trillion sustainable, smart items over the next decade. Such intelligence at scale has the power to accelerate the digital transformation across industries. Sustainability is at the very core of our technology and extends to how FlexICs enable our customers to further drive innovations and pathways through their products and services towards global net zero goals.”

Francisco Melo, President Solutions Group, Avery Dennison said: “The key to any effective collaboration is a shared mindset. Pragmatic’s innovative approach is reflective of our own, as is its commitment to helping solve business challenges. The opening of an advanced manufacturing chip facility is fantastic news for all technology innovators. Congratulations to Pragmatic on such an important and impressive achievement. I look forward to our clients harnessing the potential of Pragmatic's flexible integrated circuits as part of our evolving inlay portfolio."

Simon Little, Banking & Investments Director, UKIB and Pragmatic Board member said: “The Bank invested in Pragmatic to support low carbon domestic manufacturing of semiconductors in the UK. The official opening of Pragmatic Park in Durham marks a pivotal next step in its journey, and we look forward to seeing the long-term impact of our investment, as Pragmatic scales up its operation and creates highly skilled jobs here in the North-East.”

Niranjan Sirdeshpande, Global Head of M&G’s Catalyst strategy and Pragmatic Board member said: “The UK has a very supportive ecosystem for providing early-stage funding, but it becomes challenging for businesses looking for later stage capital. By providing growth equity to enterprising tech disruptors such as Pragmatic, M&G’s £5 billion Catalyst strategy can help them to scale, provide expertise and partner with them all the way to success. Put to work in this way, patient capital can support economic growth and capture value for peoples' pensions and savings as we transition to a more sustainable economy. We are proud to support Pragmatic’s work in Durham with tech advancement in this critical part of the UK's national infrastructure.”

About Pragmatic Semiconductor

Pragmatic is revolutionising semiconductor fabrication with ultra-low-cost, flexible integrated circuit (FlexIC) technology that makes it quick and easy to embed intelligence almost anywhere.

With rapid cycle times that substantially accelerate time to market, its foundry provides high-volume fabrication at a fraction of the cost of silicon, with a significantly lower environmental impact.

www.pragmaticsemi.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Helen Ledger, SVP of Corporate Marketing, Communications and Public Affairs,  PR@pragmaticsemi.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye